Last reviewed · How we verify
botulinum A toxin
botulinum A toxin is a Small molecule drug developed by University Hospital, Toulouse. It is currently FDA-approved. Also known as: Drug injection.
At a glance
| Generic name | botulinum A toxin |
|---|---|
| Also known as | Drug injection |
| Sponsor | University Hospital, Toulouse |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia (PHASE1, PHASE2)
- Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome (PHASE2)
- Botulinum Toxin for the Treatment of Involuntary Movement Disorders
- A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (PHASE4)
- DaxibotulinumtoxinA for Blepharospasm (PHASE2)
- Prospective, Non-interventional Study Assessing Periorbital Rejuvenation Procedure
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine (PHASE3)
- Evaluation of Spasticity, Neuropathic Pain, and Gait Analysis in Stroke Patients Receiving Tolperison Therapy After Botulinum Toxin Injection
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- botulinum A toxin CI brief — competitive landscape report
- botulinum A toxin updates RSS · CI watch RSS
- University Hospital, Toulouse portfolio CI
Frequently asked questions about botulinum A toxin
What is botulinum A toxin?
botulinum A toxin is a Small molecule drug developed by University Hospital, Toulouse.
Who makes botulinum A toxin?
botulinum A toxin is developed and marketed by University Hospital, Toulouse (see full University Hospital, Toulouse pipeline at /company/university-hospital-toulouse).
Is botulinum A toxin also known as anything else?
botulinum A toxin is also known as Drug injection.
What development phase is botulinum A toxin in?
botulinum A toxin is FDA-approved (marketed).
Related
- Manufacturer: University Hospital, Toulouse — full pipeline
- Also known as: Drug injection
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing